GlassScriptPhysician profile
James Conrad Field
NPI 1306134028
$929.77
in general payments reported to CMS, 2019-2025
12 companies · $169 in 2025
The $169 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $40.32 · 2021: $245 · 2022: $295 · 2023: $149 · 2024: $31.94 · 2025: $169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $334 · Education: $15.80.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $334.06 |
| Education | $15.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $264.48 | 2022-2023 | Jardiance, Mounjaro, Baqsimi |
| Abbott Laboratories | $221.16 | 2021-2025 | Freestyle Libre 3 |
| Amgen INC. | $111.76 | 2022-2025 | Tepezza |
| Insulet Corporation | $105.49 | 2020-2025 | Omnipod |
| Novo Nordisk INC | $57.68 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $54.41 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.96 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.01 | 2022 | |
| Dexcom, INC. | $18.76 | 2025 | Dexcom G6 Transmitter |
| Novartis Pharmaceuticals Corporation | $16.74 | 2024 | |
| Radius Health, INC. | $15.80 | 2023 | Tymlos |
| Grt US Holding, INC. | $14.52 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Field listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.